Virpharm Pharmaceutical Company was founded in 2009 by scientists and businessmen, in order to develop proprietary and innovative medicinal drugs. The action of drugs under development is mostly oriented towards liver pathology and urogenital infections. The molecules forming the basis for future drugs were synthesized about 10 years ago. In the past years, the drugs passed laboratory tests at the leading research centers of the Russian Federation. The basic results of these tests formed the basis for a number of patents pending in the Russian Federation and other countries for protection of intellectual property.